Evidence map›Paper›PMID 35622980›Full record

ArticleHuman vaccines & immunotherapeutics2022

Knowledge, attitudes, and practices of the United Arab Emirates population towards Herpes Zoster vaccination: A cross-sectional study.

Teba Al-Khalidi, Radwa Genidy, Muna Almutawa, Mohammad Mustafa, Saryia Adra, Najem Edeen Kanawati, Thureya Binashour, Hiba Jawdat Barqawi

Abstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Willingness to pay for herpes zoster vaccination in urban China.Human vaccines & immunotherapeutics · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Teba Al-KhalidiCollege of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Radwa GenidyCollege of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Muna AlmutawaCollege of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Mohammad MustafaCollege of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Saryia AdraCollege of Medicine, University of Sharjah, Sharjah, United Arab Emirates.ORCID 0000-0002-3124-7984
Najem Edeen KanawatiCollege of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Thureya BinashourCollege of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Hiba Jawdat BarqawiDepartment of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.ORCID 0000-0002-8754-9172

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herpes Zoster is a viral infection that occurs due to reactivation of the Varicella Zoster virus. A vaccine has been approved for adults aged 50 and above for the prevention of Herpes Zoster and its complications. This study aims to assess the at-risk population's awareness of the disease and its vaccine, and attitudes and practices toward the vaccine. A quantitative, observational, cross-sectional study was conducted among 420 adults above the age of 50. Non-probability, convenience sampling was used to select participants from public venues. SPSS-25 was used to analyze the data. 64.3% (n = 270) of participants heard of Herpes Zoster. 78.3% (n = 329) did not recognize the link between chickenpox and Herpes Zoster. Multiple linear regression showed that being female, Arab expatriate, or healthcare professional were the only positive predictors of Herpes Zoster knowledge. 14.8% (n = 62) heard of Herpes Zoster vaccine but 96.7% (n = 406) had not taken it. Participants with chronic diseases were 2.064 times more likely to hear about the vaccine than healthy participants (p = 0.026). Multiple linear regression showed that being a healthcare professional was the only significant predictor of Herpes Zoster vaccine knowledge. 28.1% (n = 118) were not willing to take optional vaccines. Those reluctant to take optional vaccines were 26.023 times more likely to take them if recommended by a healthcare professional (p < 0.001). Attitudes toward Herpes Zoster vaccine were generally positive; however, due to lack of knowledge, poor practices were observed. Nationwide campaigns aimed toward at-risk groups can raise awareness on Herpes Zoster and its vaccine, subsequently improving Herpes Zoster vaccination rate.

Indexed as

Herpes ZosterHerpes Zoster VaccineVaccinesAdultCross-Sectional StudiesFemaleHealth Knowledge, Attitudes, PracticeHerpesvirus 3, HumanHumansMaleUnited Arab EmiratesVaccinationHerpes Zoster VaccineVaccinesattitudeshealth educationHerpes Zosterknowledgepracticesshinglesvaccination

Identifiers

PMID35622980
PMCPMC9359366

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.